Project Grant R21NS142499
- Federal Project Grant Award Summary The University of Connecticut Health Center received a $680,941 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective July 7, 2025, through June 30, 2030. This award funds investigator-initiated basic and translational research examining the unique role of the ASPM (assembly factor for spindle...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Tufts College $426,650 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program on June 1, 2025, with a completion date of May 31, 2027. This Project Grant supports the development of hybrid differentiation strategies to generate region-specific cell populations derived from human pluripotent stem cells (hPSCs), specifically focusing on...
- Summary of Federal Project Grant Award The National Institute of Neurological Disorders and Stroke (NINDS) awarded New York Institute of Technology $459,000 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award, effective July 12, 2025, through June 30, 2028, funds a three-year research project investigating the anatomy and physiology of molecular layer heterotopia (MLH), a neuronal migration defect characterized by misplaced...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Scripps Research Institute a $710,155 Project Grant effective February 1, 2026, through January 31, 2031, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This five-year research initiative will advance fundamental understanding of post-transcriptional mechanisms governing cortical inhibitory interneuron (CIN) development and...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $637,820 to the Research Institute at Nationwide Children's Hospital on June 11, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The project grant supports forward genetic analysis research designed to identify novel genes influencing forebrain neurodevelopment, with specific emphasis on cortical structure, lamination, and...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $521,839 Project Grant to the University of California, San Diego under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program on August 7, 2025. The award supports a five-year research initiative (through July 31, 2030) investigating the molecular mechanisms of pathogenic microglial populations in central nervous system (CNS)...
- Federal Grant Award Summary Oregon Health & Science University received a $148,050 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective December 1, 2025, through May 31, 2028. This award supports investigator-initiated basic research to advance understanding of neuronal development and disease mechanisms relevant to neurodevelopmental...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $440,275 to The Research Foundation for the State University of New York (RF SUNY) on July 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) for a two-year project period concluding June 30, 2027. The project, "Systematic Discovery of OLIG2 Upstream Regulators for Central Nervous System Myelination," focuses on...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $614,009 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, awarded June 15, 2025, with completion targeted for April 30, 2030. The award funds basic and translational research investigating the molecular mechanisms of oligodendrocyte myelination and...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Johns Hopkins University a Project Grant of $426,313 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025 through July 31, 2027. The award funds research investigating surface signaling effectors of neurofilament hyperphosphorylation and their implications for neurodegenerative disease. The research...
The University of Connecticut Health Center received a $471,861 project grant award dated March 17, 2026, from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award supports a two-year research project through February 28, 2028, focused on developing transposon-mediated genetic manipulation techniques to investigate oligodendrocyte precursor cells (OPCs) and their role in synapse formation and modulation of neuronal networks. The research deliverables include the development of improved transposon-mediated conditional in utero electroporation approaches and empirical investigation of two primary hypotheses: (1) that OPCs dynamically modulate nearby neuron-neuron synapses in an activity-dependent manner following chemogenetic OPC activation, and (2) that selective deletion of the C1QL1 synaptic organizer protein gene from OPCs affects synaptic modulation. A key technical innovation involves creating novel methodologies to quantify neuron-OPC synapses while simultaneously monitoring neuron-neuron synapses, thereby eliminating confounding signals that currently limit the field's understanding of OPC participation in neural network function beyond myelination. These research outputs will advance fundamental knowledge of neurological processes and potential therapeutic mechanisms for demyelinating disorders such as multiple sclerosis.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $471.9k | 3/16/26 |